137 related articles for article (PubMed ID: 1720832)
1. Improved kidney function with cilazapril in hypertensive type II diabetics with chronic renal failure.
Bursztyn M; Kobrin I; Fidel J; Ben-Ishay D
J Cardiovasc Pharmacol; 1991 Sep; 18(3):337-41. PubMed ID: 1720832
[TBL] [Abstract][Full Text] [Related]
2. Effect of cilazapril in hypertensive patients with renal impairment.
Sánchez RA; Traballi CA; Gilbert BH; Giannone CA; Long G
J Cardiovasc Pharmacol; 1991 Feb; 17(2):222-7. PubMed ID: 1709226
[TBL] [Abstract][Full Text] [Related]
3. Effects of nitrendipine and cilazapril on renal hemodynamics and albuminuria in hypertensive patients with chronic renal failure.
Kloke HJ; Wetzels JF; van Hamersvelt HW; Koene RA; Kleinbloesem CH; Huysmans FT
J Cardiovasc Pharmacol; 1990 Dec; 16(6):924-30. PubMed ID: 1704985
[TBL] [Abstract][Full Text] [Related]
4. Antihypertensive effects of nitrendipine and cilazapril alone, and in combination in hypertensive patients with chronic renal failure.
Kloke HJ; Huysmans FT; Wetzels JF; Sluiter HE; Kleinbloesem CH; Koene RA
Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):289S-296S. PubMed ID: 2527541
[TBL] [Abstract][Full Text] [Related]
5. Outcome survey in unselected hypertensive patients with type 2 diabetes mellitus: effects of ACE inhibition.
Veelken R; Delles C; Hilgers KF; Schmieder RE
Am J Hypertens; 2001 Jul; 14(7 Pt 1):672-8. PubMed ID: 11465652
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of cilazapril in hypertensive patients with moderate to severe renal impairment.
Carlsen JE; Hansen FM; Jensen HA
Am J Med; 1989 Dec; 87(6B):79S-82S. PubMed ID: 2532466
[TBL] [Abstract][Full Text] [Related]
7. Effect of an alpha-adrenergic blocker, and ACE inhibitor and hydrochlorothiazide on blood pressure and on renal function in type 2 diabetic patients with hypertension and albuminuria. A randomized cross-over study.
Rachmani R; Levi Z; Slavachevsky I; Half-Onn E; Ravid M
Nephron; 1998 Oct; 80(2):175-82. PubMed ID: 9736816
[TBL] [Abstract][Full Text] [Related]
8. Effects of cilazapril on renal function and hormones in hypertensive patients with renal disease.
Swainson CP; Walker RJ; Bailey RR
Am J Med; 1989 Dec; 87(6B):83S-87S. PubMed ID: 2532467
[TBL] [Abstract][Full Text] [Related]
9. Kinin and angiotensin II receptor antagonists in rats with chronic renal failure: chronic effects on cardio- and renoprotection of angiotensin converting enzyme inhibitors.
Kohzuki M; Kanazawa M; Liu PF; Kamimoto M; Yoshida K; Saito T; Yasujima M; Sato T; Abe K
J Hypertens; 1995 Dec; 13(12 Pt 2):1785-90. PubMed ID: 8903652
[TBL] [Abstract][Full Text] [Related]
10. The influence of prostaglandin inhibition by indomethacin on blood pressure and renal function in hypertensive patients treated with cilazapril.
Kirch W; Stroemer K; Hoogkamer JF; Kleinbloesem CH
Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):297S-301S. PubMed ID: 2527542
[TBL] [Abstract][Full Text] [Related]
11. Antihypertensive treatment with cilazapril. Resting and exercise blood pressure, hormones and enzymes.
Breithaupt K; Belz GG; Spielmanns DG; Neis W; Kirchner P
Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):136-41. PubMed ID: 2159308
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of cilazapril in elderly patients with essential hypertension. A multicenter study.
Kobrin I; Ben-Ishay D; Bompani R; Dixon R; Hoverman RJ; Jones RW; Kögler P; Sanchez R
Am J Med; 1989 Dec; 87(6B):33S-36S. PubMed ID: 2532458
[TBL] [Abstract][Full Text] [Related]
13. [Spirapril - a new long-acting ACE inhibitor: efficacy and safety in patients with arterial hypertension in combination with diabetes mellitus and impaired kidney function].
Iakusevich VV; Mozheĭko ME; Paliutin ShKh; Berezina MIu; Martsevich SIu; Shal'nova SA; Deev AD; Kutishenko NP; Alimova EV; Koniakhina IP; Semenova IuE
Ter Arkh; 2000; 72(10):82-6. PubMed ID: 11220887
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and haemodynamic effects of the angiotensin converting enzyme inhibitor cilazapril in hypertensive patients with normal and impaired renal function.
Kloke HJ; Ambros RJ; Van Hamersvelt HW; Wetzels JF; Koene RA; Huysmans FT
Br J Clin Pharmacol; 1996 Nov; 42(5):615-20. PubMed ID: 8951193
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of cilazapril in patients with renal failure.
Fillastre JP; Moulin B; Godin M; Williams PE; Brown AN; Francis RJ; Pinta P; Manfredi R
Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):275S-282S. PubMed ID: 2527539
[TBL] [Abstract][Full Text] [Related]
16. Antihypertensive effects and pharmacokinetics of single and consecutive doses of cilazapril in hypertensive patients with normal or impaired renal function.
Shionoiri H; Gotoh E; Sugimoto K; Takasaki I; Minamisawa K; Ishii M
Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):283S-287S. PubMed ID: 2527540
[TBL] [Abstract][Full Text] [Related]
17. Long-term evaluation of cilazapril in severe hypertension. Assessment of left ventricular and renal function.
Sánchez RA; Traballi CA; Marcó EJ; Cianciulli T; Giannone CA; Ramiréz AJ
Am J Med; 1989 Dec; 87(6B):56S-60S. PubMed ID: 2532462
[TBL] [Abstract][Full Text] [Related]
18. Albuminuria in diabetes mellitus: relation to ambulatory versus office blood pressure and effects of cilazapril.
Waeber B; Weidmann P; Wohler D; Le Bloch Y
Am J Hypertens; 1996 Dec; 9(12 Pt 1):1220-7. PubMed ID: 8972894
[TBL] [Abstract][Full Text] [Related]
19. The efficacy and tolerability of fosinopril in Chinese type 2 diabetic patients with moderate renal insufficiency.
Tong PC; Ko GT; Chan WB; Ma RC; So WY; Lo MK; Lee KF; Ozaki R; Chow CC; Cockram CS; Chan JC
Diabetes Obes Metab; 2006 May; 8(3):342-7. PubMed ID: 16634995
[TBL] [Abstract][Full Text] [Related]
20. Antihypertensive effects and pharmacokinetics of single and consecutive doses of cilazapril in hypertensive patients with normal and impaired renal function.
Shionoiri H; Gotoh E; Takagi N; Takeda K; Yabana M; Kaneko Y
J Cardiovasc Pharmacol; 1988 Feb; 11(2):242-9. PubMed ID: 2452321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
